tradingkey.logo
tradingkey.logo

Case Study CyPath® Lung Detects Stage 1A Lung Cancer In High-Risk Patient With Inconclusive Imaging And Low-Risk Serum Test Results

ReutersJul 29, 2025 1:34 PM

- bioAffinity Technologies Inc BIAF.O:

  • CASE STUDY: CYPATH® LUNG DETECTS STAGE 1A LUNG CANCER IN HIGH-RISK PATIENT WITH INCONCLUSIVE IMAGING AND LOW-RISK SERUM TEST RESULTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI